- Home
- TOI vs AEON Comparison
TOI vs AEON Comparison
Compare TOI & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOI
- AEON
- Stock Information
- Founded
- TOI 2007
- AEON N/A
- Country
- TOI United States
- AEON United States
- Employees
- TOI N/A
- AEON N/A
- Industry
- TOI Medical/Nursing Services
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- TOI Health Care
- AEON Health Care
- Exchange
- TOI Nasdaq
- AEON Nasdaq
- Market Cap
- TOI 22.6M
- AEON 21.6M
- IPO Year
- TOI N/A
- AEON N/A
- Fundamental
- Price
- TOI $0.55
- AEON $0.15
- Analyst Decision
- TOI Strong Buy
- AEON Strong Buy
- Analyst Count
- TOI 1
- AEON 1
- Target Price
- TOI $2.50
- AEON $5.00
- AVG Volume (30 Days)
- TOI 951.7K
- AEON 45.9M
- Earning Date
- TOI 11-13-2024
- AEON 11-13-2024
- Dividend Yield
- TOI N/A
- AEON N/A
- EPS Growth
- TOI N/A
- AEON N/A
- EPS
- TOI N/A
- AEON 0.34
- Revenue
- TOI $378,933,000.00
- AEON N/A
- Revenue This Year
- TOI $29.17
- AEON N/A
- Revenue Next Year
- TOI $16.43
- AEON N/A
- P/E Ratio
- TOI N/A
- AEON $0.45
- Revenue Growth
- TOI 22.29
- AEON N/A
- 52 Week Low
- TOI $0.13
- AEON $0.10
- 52 Week High
- TOI $2.45
- AEON $17.17
- Technical
- Relative Strength Index (RSI)
- TOI 84.45
- AEON 27.61
- Support Level
- TOI $0.25
- AEON $0.10
- Resistance Level
- TOI $0.50
- AEON $0.22
- Average True Range (ATR)
- TOI 0.07
- AEON 0.05
- MACD
- TOI 0.02
- AEON -0.02
- Stochastic Oscillator
- TOI 81.46
- AEON 10.04
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.